During the past decade, Cardiology of Atlanta conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology of Atlanta" #1 collaborator was "Medtronic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology of Atlanta" are "Anti-coagulation Therapy" (1 trials), "Atrial Fibrillation" (1 trials), "DVT" (1 trials), "Heart Failure, Congestive" (1 trials) and "Joint Surgery Multiple" (1 trials). Many other conditions were trialed in "Cardiology of Atlanta" in a lesser frequency.

Most popular intervention types in "Cardiology of Atlanta" are "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Warfarin GenoSTAT Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology of Atlanta" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology of Atlanta". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cardiology of Atlanta, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology of Atlanta, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".